X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (514) 514
Paper (368) 368
Publication (259) 259
Report (119) 119
Data Set (7) 7
Book Chapter (2) 2
Book / eBook (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (415) 415
particle physics (368) 368
high energy physics - experiment (361) 361
physics (360) 360
physics - high energy physics - experiment (348) 348
cern lhc coll (294) 294
high energy physics (285) 285
experimental results (281) 281
hep (199) 199
p p: scattering (189) 189
phenomenology (185) 185
p p: colliding beams (175) 175
13000 gev-cms (166) 166
ex (154) 154
physics of elementary particles and fields (138) 138
nuclear experiment (130) 130
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (109) 109
scattering [p p] (107) 107
colliding beams [p p] (101) 101
atlas (97) 97
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (87) 87
8000 gev-cms (77) 77
subatomic physics (71) 71
subatomär fysik (71) 71
background (70) 70
hadron-hadron scattering (62) 62
physical sciences (62) 62
fysik (61) 61
natural sciences (58) 58
naturvetenskap (58) 58
particle physics - experiment (57) 57
astrophysics (56) 56
mass dependence (56) 56
物理学 (48) 48
high energy astrophysical phenomena (47) 47
data analysis method (44) 44
transverse momentum dependence (43) 43
physics, particles & fields (42) 42
bottom: particle identification (41) 41
humans (39) 39
index medicus (36) 36
z0: leptonic decay (36) 36
jet: bottom (35) 35
rapidity dependence (34) 34
cern lab (33) 33
channel cross section: branching ratio: upper limit (33) 33
differential cross section: measured (33) 33
final state:jet lepton (33) 33
transverse momentum: missing-energy (32) 32
channel cross section: upper limit (31) 31
ciências físicas [ciências naturais] (30) 30
male (30) 30
mass spectrum: (30) 30
science & technology (30) 30
top: pair production (29) 29
elementary particles, quantum field theory (28) 28
female (28) 28
hep-ex (28) 28
kinematics (28) 28
numerical calculations: monte carlo (28) 28
quantum field theories, string theory (28) 28
middle aged (26) 26
channel cross section: measured (25) 25
collisions (24) 24
electroweak interaction (24) 24
final state:jet dilepton (24) 24
higgs particle: hadroproduction (24) 24
large hadron collider (24) 24
supersymmetry (24) 24
aged (23) 23
astronomy, astrophysics and cosmology (23) 23
phase space (23) 23
sensitivity (23) 23
instrumentation and detectors (21) 21
leptonic decay [z0] (21) 21
measurement science and instrumentation (21) 21
nuclear and particle physics. atomic energy. radioactivity (21) 21
nuclear energy (21) 21
nuclear physics, heavy ions, hadrons (21) 21
higgs particle: hadronic decay (20) 20
jet: transverse momentum (20) 20
measured [differential cross section] (20) 20
monte carlo [numerical calculations] (20) 20
nuclear and high energy physics (20) 20
w: leptonic decay (20) 20
bottom: pair production (19) 19
final state:jet (19) 19
w: hadronic decay (19) 19
missing-energy [transverse momentum] (18) 18
nucl (18) 18
physics and astronomy (18) 18
quantum chromodynamics: perturbation theory (18) 18
structure (18) 18
nuclear physics (17) 17
pair production [top] (17) 17
physik (17) 17
regular - experimental physics (17) 17
transverse momentum (17) 17
benchmark (16) 16
oncology (16) 16
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 15, pp. 1408 - 1416
A dose-intense infusional chemotherapy program plus rituximab had a high degree of efficacy in patients with primary mediastinal B-cell lymphoma, which is... 
MEDICINE, GENERAL & INTERNAL | AMPLIFICATION | MANAGEMENT | EFFICACY | DOXORUBICIN | SCLEROSIS | CLASSICAL HODGKIN LYMPHOMA | RADIOTHERAPY | EXPRESSION | GERMINAL-CENTER | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Filgrastim | Dose-Response Relationship, Drug | Young Adult | Vincristine - administration & dosage | Adult | Female | Retrospective Studies | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Kaplan-Meier Estimate | Rituximab | Stroke Volume - drug effects | Etoposide - administration & dosage | Recombinant Proteins - administration & dosage | Disease-Free Survival | Vincristine - adverse effects | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Granulocyte Colony-Stimulating Factor - administration & dosage | Drugs | Dose-response relationship (Biochemistry) | Usage | Cyclophosphamide | Patient outcomes | Dosage and administration | Lymphomas | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | Doxorubicin | Medical research | Nuclear magnetic resonance--NMR | Disease | Review boards | Genes | Etoposide | Prednisone | Radiation therapy | Kinases | Vincristine | Patients | Morbidity | Chemotherapy | Lymphocytes B | Remission | Mutation | Hodgkin's disease | B-cell lymphoma
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2012, Volume 104, Issue 7, p. 528
MicroRNA (miR) expression may have prognostic value for many types of cancers. However, the miR literature comprises many small studies. We systematically... 
Systematic review | Oncology | Ribonucleic acid--RNA | Gene expression | Clinical outcomes
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2018, Volume 36, Issue 28, pp. 2845 - 2853
PurposeOutcomes for patients with diffuse large B-cell lymphoma remain heterogeneous, with existing methods failing to consistently predict treatment failure.... 
FDG-PET | SURVIVAL | INTERIM | CONSOLIDATION | THERAPY | ONCOLOGY | END-POINT | HODGKIN | CHEMOTHERAPY | TRANSPLANTATION | Life Sciences | Cancer | ORIGINAL REPORTS
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 4940 - 4940
Abstract Abstract 4940 Background: Bendamustine has evolved as an increasingly used chemotherapeutic agent for diverse lymphomas in the United States (US) and... 
Journal Article
Chemical Research in Toxicology, ISSN 0893-228X, 09/2006, Volume 19, Issue 9, pp. 1215 - 1220
A dedicated excision repair pathway, termed transcription-coupled repair (TCR), targets the removal of DNA lesions from transcribed strands of expressed genes.... 
RNA-POLYMERASE-II | RAT-LIVER | CHEMISTRY, MEDICINAL | BASE DAMAGES | ESCHERICHIA-COLI | CHEMISTRY, MULTIDISCIPLINARY | LESIONS | 8-OXOGUANINE | REPAIR | GENE | ELONGATION | PURIFICATION | TOXICOLOGY | DNA - genetics | Hydrolysis | DNA - chemistry | Base Sequence | Templates, Genetic | RNA Polymerase II - genetics | Transcription, Genetic | DNA Primers
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 12/2011, Volume 81, Issue 5, pp. 1374 - 1379
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 59 - 59
Abstract Abstract 59 Introduction: CD22 is a lineage marker expressed in most B-cell lymphomas. DCDT2980S is an ADC consisting of an anti-CD22 monoclonal... 
Journal Article
Blood, ISSN 0006-4971, 11/2009, Volume 114, Issue 22, pp. 1563 - 1563
Abstract Abstract 1563 Poster Board I-586 Background In Hodgkin's Disease (HD) the role of FDG-PET/CT is well established in staging and assessment of... 
Journal Article